Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model
Improved operating performance by reducing net loss by $52.5 million; reported net…
TELA Bio to Participate in Piper Sandlers 36th Annual Healthcare Conference
November 19, 2024 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
-Data demonstrate characteristics essential for treatment of autoimmune diseases, including robust tissue…
Hinge Bio Presents Preclinical Data from its GEM-DIMER Programs Targeting B Cell Depletion at the American College of Rheumatology (ACR) Convergence 2024
Hinge Bio’s GEM-DIMER™ platform demonstrates differentiated in vivo and in vitro data…
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer’s Disease
Boca Raton, Florida, Nov. 13, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:…
A2 Bio Highlights Progress of Tmod CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
Oral presentation provides update on enhancements to improve participant diversity and enrollment…
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX),…
Binance Labs Invests in BIO Protocol to Accelerate Decentralized Science (DeSci) Funding
Main Takeaways: Binance Labs has invested in BIO Protocol, a pioneering protocol transforming…
SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update
Company announced completed Phase 1 enrollment for SAB-142 with no observation of…
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Companys Novel Business Model as Key to Sustainable Success through Patient Affordability
Tevogen Bio is a fully functional biotech, with investor-valued assets over $10…